Agatsa has emerged as one of the leader in healthcare technology, revolutionizing cardiac care with its innovative solutions.
Founded by pioneering engineers Rahul and Neha Rastogi, Agatsa has evolved from a humble matchbox-sized prototype creator into a provider of advanced heart health monitoring devices.
From Concept to Market
Agatsa’s story began in 2014, when Rahul and Neha Rastogi developed the first handheld ECG prototype, crafted using a humble matchbox.
This early innovation laid the foundation for what would evolve into the acclaimed SanketLife series.
By 2017, their creation made its debut in the market, introducing a new era of accessible cardiac care.
This initial success was marked by the launch of the SanketLife device and its accompanying app, a significant milestone in democratizing cardiac health monitoring.
After launch they received numerous feedback. In 2018, they responded to user feedback with the launch of SanketLife 2.0, an upgraded version featuring advanced technology and a user-friendly interface.
This was followed by the introduction of SanketLife Pro Plus in 2019, a hybrid portable ECG device designed to cater to diverse needs with or without leads.
Each innovation was a step toward refining and enhancing cardiac care.
Pioneering Technology and Features
The company’s devices are designed to offer a comprehensive range of features that cater to different user needs.
Agatsa’s flagship products, including the Health360 and SanketLife series, are equipped with 12-lead ECG capabilities, real-time detection, and cloud backup of reports.
These devices are not only compact and touch-based but also medically tested to ensure accuracy and reliability.
The Health360, represents the pinnacle of Agatsa’s innovation.
It offers a complete health monitoring experience, including vital signs like blood pressure, SpO2, temperature, and breathing rate, alongside ECG monitoring.
Its seamless integration into daily health routines makes it an invaluable tool for individuals seeking to stay on top of their health.
Similarly, the SanketLife Pro Plus Combo, offers a miniaturized digital ECG setup ideal for doctors and professionals.
Its compact design and advanced technology facilitate precise and reliable heart monitoring, with the added benefit of instantaneous report sharing for timely medical intervention.
Addressing Diverse Needs
Agatsa’s innovations cater to a wide array of users, from fitness enthusiasts to high-risk patients.
For fitness enthusiasts, the SanketLife devices offer real-time monitoring of heart rate, VO2 max, and heart rate variability (HRV), helping users track progress and adjust workout intensity based on their heart health.
High-risk patients, on the other hand, benefit from the early detection capabilities of Agatsa’s devices.
The SanketLife ECG enables instant detection of 15 fatal heart conditions, providing accurate ECG results in seconds.
The option for 24×7 cardiologist connect ensures that high-risk patients receive timely medical advice, a critical feature for those who need constant monitoring.
Young adults also find value in Agatsa’s products.
The ability to monitor stress levels and anxiety with a touch-based, keychain-sized device provides insights into whether these issues are due to lifestyle or underlying heart disease.
This proactive approach empowers users to make informed decisions about their health.
Transforming Healthcare with AI and Cloud Technology
One of the standout features of Agatsa’s devices is their integration with AI and cloud technology.
The cloud backup feature ensures that users’ medical histories are stored securely and can be accessed easily.
This not only facilitates convenient tracking of medical progress but also enables seamless sharing of reports with doctors and family members.
The AI-powered technology in Agatsa’s devices helps in detecting even minor abnormalities, providing users with critical insights into their heart health.
This proactive approach allows for early intervention and prevention of potential heart conditions, aligning with Agatsa’s mission of bridging the gap between individuals and doctors.
Expanding Reach and Impact
As of 2024, Agatsa has achieved significant milestones, with over 48,000 app downloads, 45,000 diseases captured, and 1 million ECGs taken.
The company’s impact is further underscored by the sale of 25,000 devices and the saving of 100,000 lives.
With 36 awards recognizing their innovation and excellence, Agatsa continues to lead the way in transforming cardiac care.
The company’s vision extends beyond just product innovation. Agatsa aims to democratize high-end cardiac care technology, breaking barriers of location and cost to make it accessible to everyone.
Their commitment to research and development, evident in the launch of the MultiVital device and ongoing advancements in AI technology, underscores their dedication to improving cardiac health outcomes.
A Commitment to Core Values
At the core of Agatsa’s operations are values of respect, inclusion, and excellence.
These values are not just reflected in their products but are embedded in their organizational culture.
Agatsa’s core purpose and values drive their commitment to providing innovative, accessible, and effective cardiac care solutions.
Agatsa’s journey from a small prototype to a leader in cardiac health technology is a remarkable story of innovation and dedication.
Their cutting-edge devices, commitment to AI and cloud technology, and focus on diverse user needs have set a new standard in cardiac care.
As they continue to advance and expand, Agatsa remains a pioneer in making cardiac health monitoring an integral part of everyday life, ensuring that timely and effective care is within reach for everyone.
